DILAUDID

This brand name is authorized in Australia, Canada, United States

Active ingredients

The drug DILAUDID contains one active pharmaceutical ingredient (API):

1 Hydromorphone UNII L960UP2KRW - HYDROMORPHONE HYDROCHLORIDE

Hydromorphone is an agonist of mu receptors. The pharmacological actions of hydromorphone and morphine do not differ significantly. Hydromorphone and related opioids produce their major effects on the central nervous system and bowel. Hydromorphone is indicated for the relief of severe pain in cancer. Read about Hydromorphone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
DILAUDID Solution for injection	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N02AA03	Hydromorphone	N Nervous system → N02 Analgesics → N02A Opioids → N02AA Natural opium alkaloids
Discover more medicines within N02AA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 11467M, 11479E, 12010D, 12016K, 12032G, 12045Y, 12046B, 12047C, 12484C, 12485D, 12493M, 12497R, 12515Q, 12531M, 5115F, 5116G, 5117H, 8420E, 8421F, 8541M, 8542N, 8543P
Country: CA	Health Products and Food Branch	Identifier(s): 00125083, 00125121, 00705438, 00786543
Country: US	FDA, National Drug Code	Identifier(s): 42858-122, 42858-234, 42858-338, 42858-416, 76045-009, 76045-010, 76045-121